610 results on '"Cannavò S"'
Search Results
2. Disease control of acromegaly does not prevent excess mortality in the long term: results of a nationwide survey in Italy
3. Endocrine disruptors, aryl hydrocarbon receptor and cortisol secretion
4. Cardiovascular and metabolic comorbidities in patients with thyroid nodules: the impact of incidental diagnosis
5. Predictors of thyroid adverse events during cancer immunotherapy: a real-life experience at a single center
6. Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing’s disease: a monocentric experience in Southern Italy
7. Appropriate management of growth hormone deficiency during the age of transition: an Italian Delphi consensus statement
8. Are there country-specific differences in the use of pegvisomant for acromegaly in clinical practice? An analysis from ACROSTUDY
9. Global Cushing’s disease epidemiology: a systematic review and meta-analysis of observational studies
10. 34P Impact of environmental pollution on adrenocortical carcinoma in Italy
11. What we have to know about corticosteroids use during Sars-Cov-2 infection
12. What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study
13. The prevalence of silent acromegaly in prolactinomas is very low
14. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto’s thyroiditis
15. MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior
16. Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis
17. Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know)
18. GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegaly
19. Cardiovascular and metabolic comorbidities in patients with thyroid nodules: the impact of incidental diagnosis
20. Acromegaly, genetic variants of the aryl hydrocarbon receptor pathway and environmental burden
21. COVID-19 outbreak and steroids administration: are patients treated for Sars-Cov-2 at risk of adrenal insufficiency?
22. Pegvisomant in acromegaly: an update
23. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto’s thyroiditis
24. MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior
25. Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study
26. Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA
27. The boxer world heavyweight champion Primo Carnera portrayed by Giacomo Balla
28. Evaluation of cutaneous surface parameters in psoriatic patients
29. ACROSTUDY: the Italian experience
30. Clinical Consequences of Variable Results in the Measurement of Free Thyroid Hormones: Unusual Presentation of a Family with a Novel Variant in the THRB Gene Causing Resistance to Thyroid Hormone Syndrome
31. Conventional and Nuclear Medicine Imaging in Ectopic Cushingʼs Syndrome: A Systematic Review
32. A case of hypertrichotic smooth muscle hamartoma: is it an amelanotic Becker naevus?
33. Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry*
34. Chronic idiopathic urticaria and Graves’ disease
35. Systemic hypertension counteracts potential benefits of growth hormone replacement therapy on left ventricular remodeling in adults with growth hormone deficiency
36. Extensionality and Randomness in Probability Sequences
37. On the Verifiability of Universal Empirical Statements
38. First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment
39. Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL
40. High prevalence of coronary calcifications and increased risk for coronary heart disease in adults with growth hormone deficiency
41. Pityriasis rosea of Gibert: immunological aspects
42. Temporary radiation-induced alopecia after embolization of a cerebral arteriovenous malformation
43. Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: results from Italy
44. Primary empty sella: Why and when to investigate hypothalamic-pituitary function
45. Italian Guidelines in patch testing - Adapted from the European Society of Contact Dermatitis (ESCD)
46. Non-functioning pituitary adenomas infrequently harbor G-protein gene mutations
47. Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas
48. Pegvisomant in acromegaly: Why, when, how
49. Correction to: Pegvisomant in acromegaly: an update
50. Hypopituitarism and rare dermatological diseases: an intriguing case of xanthoma disseminatum
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.